Publication Name	World Journal of Experimental Medicine
Manuscript ID	66940
Country	United States

Received	2021-04-09 20:30
Peer-Review Started	2021-04-09 20:32
To Make the First Decision
Return for Revision	2021-05-14 00:15
Revised	2021-06-01 20:49
Second Decision	2021-09-01 02:13
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-09-01 09:34
Articles in Press	2021-09-01 09:34
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-09-14 20:35
Typeset the Manuscript	2021-11-11 02:17
Publish the Manuscript Online	2021-11-17 10:11

ISSN	2220-315x (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Minireviews
Article Title	Emerging role of cell free DNA in kidney transplantation
Manuscript Source	Invited Manuscript
All Author List	Bhavna Chopra and Kalathil K Sureshkumar
ORCID	Author(s) ORCID Number Bhavna Chopra http://orcid.org/0000-0002-9710-0483 Kalathil K Sureshkumar http://orcid.org/0000-0002-9637-0879
Funding Agency and Grant Number
Corresponding Author	Kalathil K Sureshkumar, FRCP, MD, Associate Professor, Division of Nephrology, Department of medicine, Allegheny General Hospital, Allegheny Health Network, 320 East North Avenue, Pittsburgh, PA 15212, United States. kalathil.sureshkumar@ahn.org
Key Words	Biomarker; Donor derived cell free DNA; Kidney allograft outcomes; Kidney transplant; Allograft biopsy
Core Tip	Donor derived cell free DNA (dd-cfDNA) is now available as a noninvasive biomarker in evaluating risk of rejection in kidney allografts and other organ transplants. The technology utilizes next generation sequencing and does not require donor genotyping. In this review we discuss the current literature on the utility of dd-cfDNA in kidney transplantation, the limitations and future directions.
Publish Date	2021-11-17 10:11
Citation	Chopra B, Sureshkumar KK. Emerging role of cell free DNA in kidney transplantation. World J Exp Med 2021; 11(5): 55-65
URL	https://www.wjgnet.com/2220-315x/full/v11/i5/55.htm
DOI	https://dx.doi.org/10.5493/wjem.v11.i5.55

Full Article (PDF)	WJEM-11-55.pdf
Full Article (Word)	WJEM-11-55.docx
Manuscript File	66940-Review-Filipodia-CL.docx
Answering Reviewers	66940-Answering reviewers.pdf
Audio Core Tip	66940-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66940-Conflict-of-interest statement.pdf
Copyright License Agreement	66940-Copyright license agreement.pdf
Peer-review Report	66940-Peer-review(s).pdf
Scientific Misconduct Check	66940-Scientific misconduct check.pdf
Scientific Editor Work List	66940-Scientific editor work list.pdf
CrossCheck Report	66940-CrossCheck report.pdf